However, we did not observe a systematic difference in sensitivity of HPV16 early protein serology in the subgroup of studies using one histopathological reference method, i.e., p16 IHC or ISH in contrast with studies using combinations of molecular methods to determine molecular HPV tumor status. Here, CDKN2A is linked to neoplasm.